Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-17A: Possible mediator and therapeutic target in hypertension.
Rodrigues-Diez RR, Tejera-Muñoz A, Orejudo M, Marquez-Exposito L, Santos L, Rayego-Mateos S, Cantero-Navarro E, Tejedor-Santamaria L, Marchant V, Ortiz A, Egido J, Mezzano S, Selgas R, Navarro-González JF, Valdivielso JM, Lavoz C, Ruiz-Ortega M. Rodrigues-Diez RR, et al. Among authors: orejudo m. Nefrologia (Engl Ed). 2021 May-Jun;41(3):244-257. doi: 10.1016/j.nefro.2020.11.009. Epub 2021 Mar 26. Nefrologia (Engl Ed). 2021. PMID: 33775443 Free article. Review. English, Spanish.
The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response.
Rodrigues-Díez R, Rodrigues-Díez RR, Rayego-Mateos S, Suarez-Alvarez B, Lavoz C, Stark Aroeira L, Sánchez-López E, Orejudo M, Alique M, Lopez-Larrea C, Ortiz A, Egido J, Ruiz-Ortega M. Rodrigues-Díez R, et al. Among authors: orejudo m. Lab Invest. 2013 Jul;93(7):812-24. doi: 10.1038/labinvest.2013.67. Epub 2013 May 6. Lab Invest. 2013. PMID: 23648563 Free article.
IL-17A is a novel player in dialysis-induced peritoneal damage.
Rodrigues-Díez R, Aroeira LS, Orejudo M, Bajo MA, Heffernan JJ, Rodrigues-Díez RR, Rayego-Mateos S, Ortiz A, Gonzalez-Mateo G, López-Cabrera M, Selgas R, Egido J, Ruiz-Ortega M. Rodrigues-Díez R, et al. Among authors: orejudo m. Kidney Int. 2014 Aug;86(2):303-15. doi: 10.1038/ki.2014.33. Epub 2014 Feb 19. Kidney Int. 2014. PMID: 24552849 Free article.
The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.
Rodrigues-Diez RR, Garcia-Redondo AB, Orejudo M, Rodrigues-Diez R, Briones AM, Bosch-Panadero E, Kery G, Pato J, Ortiz A, Salaices M, Egido J, Ruiz-Ortega M. Rodrigues-Diez RR, et al. Among authors: orejudo m. Antioxid Redox Signal. 2015 Jan 1;22(1):29-47. doi: 10.1089/ars.2013.5500. Antioxid Redox Signal. 2015. PMID: 25065408 Free PMC article.
Could Notch signaling pathway be a potential therapeutic option in renal diseases?
Marquez-Exposito L, Cantero-Navarro E, Lavoz C, Fierro-Fernández M, Poveda J, Rayego-Mateos S, Rodrigues-Diez RR, Morgado-Pascual JL, Orejudo M, Mezzano S, Ruiz-Ortega M. Marquez-Exposito L, et al. Among authors: orejudo m. Nefrologia (Engl Ed). 2018 Sep-Oct;38(5):466-475. doi: 10.1016/j.nefro.2017.11.027. Epub 2018 Feb 10. Nefrologia (Engl Ed). 2018. PMID: 29439807 Free article. Review. English, Spanish.
Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
Lavoz C, Rayego-Mateos S, Orejudo M, Opazo-Ríos L, Marchant V, Marquez-Exposito L, Tejera-Muñoz A, Navarro-González JF, Droguett A, Ortiz A, Egido J, Mezzano S, Rodrigues-Diez RR, Ruiz-Ortega M. Lavoz C, et al. Among authors: orejudo m. J Clin Med. 2020 Jan 19;9(1):272. doi: 10.3390/jcm9010272. J Clin Med. 2020. PMID: 31963845 Free PMC article. Review.
23 results